Mackenzie Tatananni
Walgreens stock rose on Tuesday as an earnings beat lifted shares of the pharmacy chain, which is set to go private sometime in the calendar fourth quarter.
Walgreens posted adjusted earnings of 63 cents a share for the quarter ended Feb. 28, topping analysts' calls for 53 cents, according to FactSet. A loss of $2.853 billion in the quarter was narrower than the $5.908 billion loss recorded a year ago.
Quarterly sales climbed to $38.588 billion, up from $37.052 billion in the previous year and above the $37.971 billion Wall Street anticipated. The strong fiscal-second-quarter print gave shares a boost on Tuesday, with Walgreens stock rising 1.5% to $10.88 as the S&P 500 gained 3.7%.
Last month, Walgreens confirmed that it had struck an agreement with private-equity firm Sycamore Partners to be taken private. The company consequently withdrew its fiscal 2025 guidance, citing the buyout deal.
After nearly a century as a public company, the beleaguered retailer will be taken off the market as it faces billions of dollars of debt as well as opioid liabilities. The deal is valued at $23.7 billion, and the cash portion represents $10 billion of that.
Write to Mackenzie Tatananni at mackenzie.tatananni@barrons.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 08, 2025 10:23 ET (14:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。